Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory
We came across a bullish thesis on Rocket Pharmaceuticals, Inc. (RCKT) on Twitter by sharkbiotech. In this article, we will ...
Fierce Biotech3d
Amgen ignites Rocket program with phase 3 wins for $400M eczema prospect
Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...
Shrimp shell material may control space drug delivery
By sending nanoemulsion formulations on a space flight, scientists are investigating whether chitosan—a material derived from ...
New Scientist14d
Medicines made in space set to touch down in Australian outback
Varda, a US firm planning to manufacture pharmaceuticals in low Earth orbit, is expecting its second capsule to return to ...
Zacks Investment Research on MSN3d
AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies
Amgen AMGN announced positive results from two clinical studies, IGNITE and SHUTTLE, which are part of the phase III ROCKET ...
pharmaphorum5d
Rocket Pharmaceuticals in orbit after gene therapy read-out
Shares in Rocket Pharmaceuticals have been living up to their name, shooting up following encouraging early-stage clinical trial results from a gene therapy for a serious inherited rare heart disease.